Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 10Active not recruiting 2Terminated 1Suspended 1Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Breast 1

Conditions

Pediatric Solid Tumor 1Breast Screening 1

Interventions

Specimen Handling 219Magnetic Resonance Spectroscopy 195pembrolizumab 186Carboplatin 161Cisplatin 131Biopsy 129Nivolumab 121Paclitaxel 107Cyclophosphamide 104Radiotherapy 99Gemcitabine 98Dexamethasone 87durvalumab 85atezolizumab 70Rituximab 66Lenalidomide 65Radiation 64Doxorubicin 63Pemetrexed 62Bevacizumab 58Docetaxel 57Etoposide 56olaparib 50Ipilimumab 49Fluorouracil 48Taxes 47Prednisone 47Oxaliplatin 47Vincristine 45Radiosurgery 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Genetic Testing × 90 days × Clear all
NCT03233191 2026-05-05

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
108,508 enrolled
Breast

Breast Screening

NCT02520713 2026-04-28

The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

Dana-Farber Cancer Institute

Active not recruiting
825 enrolled
Other solid neoplasm

Pediatric Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡